SCHEMBL24528848

SCHEMBL24528848

CN(C(=O)OC(C)(C)C)C(c1ccc(C(=O)N2CCC(=O)CC2)cc1)C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 2/20 0.40
KMT2A Q03164 6/20 0.39
MEN1 O00255 4/20 0.39
ABL1 P00519 1/20 0.39
RIN1 Q13671 1/20 0.39
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
NAMPT P43490 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HTT P42858 2/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
EPHX2 P34913 1/20 0.34
POLB P06746 2/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
FASN P49327 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24528856 0.82 KDM4E (0.36) KMT2AMEN1ALDH1A1SMN1; SMN2HTT
SCHEMBL24528859 0.78 AAK1 (0.39) SMN1; SMN2NPC1RAB9APOLB
SCHEMBL24528858 0.76 BCL2A1 (0.39) ALDH1A1L3MBTL1HTTNPC1MAPT
SCHEMBL24528864 0.75 BCL2A1 (0.43) ALDH1A1L3MBTL1HTTNPC1MAPT
SCHEMBL24528855 0.73 ALDH1A1 (0.42) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL24120195 0.69 HPGD (0.61) L3MBTL3KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL19670980 0.68 ALDH1A1 (0.73) KMT2AMEN1ALDH1A1SMN1; SMN2LMNA
SCHEMBL16823464 0.67 MEN1 (0.71) KMT2AMEN1ABL1ALDH1A1SMN1; SMN2
SCHEMBL16845160 0.66 MEN1 (0.55) KMT2AMEN1ABL1ALDH1A1SMN1; SMN2
SCHEMBL16845139 0.66 MEN1 (0.51) KMT2AMEN1ALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022129925-A1 NOVEL BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2022-06-23 WO disclosed